Skip to search formSkip to main contentSkip to account menu

NCI CTEP SDC Gastroesophageal Cancer Sub-Category Terminology

Known as: Gastroesophageal Cancer, NCI CTEP Simple Disease Classification Gastroesophageal Cancer Sub-Category Terminology 
Gastroesophageal Cancer is an NCI Cancer Therapeutic Evaluation Program (CTEP) Simplified Disease Classification (SDC) category used to organize… 
National Institutes of Health

Related topics

Related topics

6 relations
Adenocarcinoma Of EsophagusAdenocarcinoma of the Gastroesophageal JunctionEsophageal carcinomaGastric Adenocarcinoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Effectiveness of Trastuzumab in Routine Clinical Practice: A Population-based Study of Patients with HER-2-positive Oesophageal, Gastroesophageal and Gastric Cancer.
2017
2017
Quality of life and self-management strategies after gastroesophageal cancer surgery.
159Background: Gastroesophageal cancer surgery can result in significant morbidity and decreased quality of life (QOL). The… 
2016
2016
Evaluation of Response to Preoperative Chemotherapy Versus Surgery Alone in Gastroesophageal Cancer: Tumor Resectability, Pathologic Results and Post-Operative Complications.
Gastroesophageal cancer is one of the most common types of cancer worldwide. Despite significant developments in management, 5… 
2016
2016
Heterogeneous Her2/Neu expression in gastric and gastroesophageal cancer.
2010
2010
Plasma vitamin A and E levels in patients with gastroesophageal cancer in Eastern Anatolia
Gastrointestinal system (GIS) cancers account for a significant percentage of morbidity and mortality worldwide. Free radicals… 
2009
2009
Biweekly cetuximab and irinotecan as second-line therapy to patients with platinium-resistant gastroesophageal cancer.
e15624 Background: There is no established 2nd line therapy for patients (pts) with advanced gastroesophageal (GE) cancer. In… 
2009
2009
Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States.
AIM To assess the use of capecitabine-based therapy and associated complication rates in patients with gastroesophageal cancer… 
Highly Cited
2008
Highly Cited
2008
Comparison of an inflammation‐based prognostic score (GPS) with performance status (ECOG‐ps) in patients receiving palliative chemotherapy for gastroesophageal cancer
Aim:  The aim of the present study was to compare an inflammation‐based prognostic score (Glasgow Prognostic Score, GPS) with… 
2008
2008
Therapy of Localized Esophageal Cancer: It Is Time to Reengineer Our Investigative Strategies
[12] and surgery [13] can result in considerable morbidity and/or mortality. Why do we subject every patient to all these… 
1999
1999
Epirubicin, cisplatin and oral UFT with leucovorin ('ECU'): a phase I-II study in patients with advanced upper gastrointestinal tract cancer.
BACKGROUND ECF (epirubicin, cisplatin, protracted venous fluorouracil) is superior to FAMTX in gastroesophageal cancer, but… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)